drugset / Trial / NCT04451174

Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia

NCT04451174 ↗

Phase 3 Terminated 60 enrolled University of Chile
RandomizedParallel-groupSingle-blindTreatment

Summary

Steroids has shown benefits in COVID19 patients in observational studies. We hypothesized that early use of corticosteroids, low dose, in mild disease, can decrease progression to respiratory failure and death.

Timeline

Start
2020-06-23
Primary completion
2021-01-30
Completion
2021-01-30

Outcome

Outcome not reported

Stopped: “Corticosteroid use approval”

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 20 mg —

Indications